Cargando…
Regulatory evaluation of biosimilars throughout their product life-cycle
The World Health Assembly in 2014 adopted a resolution that recognized the importance of increasing access to biotherapeutic products, of improving their affordability and of ensuring their quality, safety and efficacy. Biosimilars are biotherapeutic products similar to already licensed reference pr...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
World Health Organization
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5872015/ https://www.ncbi.nlm.nih.gov/pubmed/29695884 http://dx.doi.org/10.2471/BLT.17.206284 |